StonvexLoading…
StonvexStonvexStonvexCore line items from NTSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 |
|---|---|---|---|
Revenue | $709.00M | $538.27M | $406.88M |
Operating Income | $-652.58M | $-255.74M | $-312.80M |
Net Income | $-679.39M | $-354.51M | $-344.85M |
EPS (Diluted) | $-3.18 | $-3.64 | $-3.77 |
Total Assets | $1.77B | $858.51M | Not available |
Total Liabilities | $1.58B | $1.34B | Not available |
Cash & Equivalents | $432.58M | $166.01M | Not available |
Free Cash Flow OCF − CapEx | $15.15M | $-144.37M | $-197.78M |
Shares Outstanding | 213.90M | 97.52M | 91.39M |